PDA

View Full Version : Molecular engineering of short half-life small peptides (VIP, {alpha}MSH and {gamma}3MSH) fused



RSS Feed
10-15-2011, 07:03 AM
Ann Rheum Dis (http://www.hubmed.org/fulltext.cgi?uids=21998117). 2011 Oct 13;
Vessillier S, Adams G, Montero-Melendez T, Jones R, Seed M, Perretti M, Chernajovsky Y
OBJECTIVE: To facilitate the targeting to inflammation sites of small anti-inflammatory peptides, with short half-lives, by fusion with the latency-associated peptide (LAP) of transforming growth factor